• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Ipca Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524494
INE571A01038
314.5139046
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
IPCALAB
34.84
40232.41
EPS(TTM)
Face Value()
Div & Yield %
45.52
1
0.38
 

Syngene International consolidated net profit declines 19.31% in the March 2026 quarter
Apr 30,2026
Net profit of Syngene International declined 19.31% to Rs 147.90 crore in the quarter ended March 2026 as against Rs 183.30 crore during the previous quarter ended March 2025. Sales rose 1.82% to Rs 1036.50 crore in the quarter ended March 2026 as against Rs 1018.00 crore during the previous quarter ended March 2025.

For the full year,net profit declined 36.17% to Rs 316.70 crore in the year ended March 2026 as against Rs 496.20 crore during the previous year ended March 2025. Sales rose 2.64% to Rs 3738.70 crore in the year ended March 2026 as against Rs 3642.40 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1036.501018.00 2 3738.703642.40 3
OPM %29.2733.75 -24.5728.60 -
PBDT313.50346.60 -10 940.401060.50 -11
PBT202.00240.50 -16 487.50627.90 -22
NP147.90183.30 -19 316.70496.20 -36